Key Points
- EVP Erik Phelps sold 1,302 shares of Tempus AI on December 16 at an average price of $67.42 for $87,780.84, trimming his stake by 1.44% to 89,280 shares valued at about $6.02 million.
- Tempus AI beat estimates in its most recent quarter (EPS -$0.11 vs. -$0.16 est.; revenue $334.2M, up 84.7% YoY) but remains unprofitable with negative ROE and analysts projecting a -6.15 EPS for the fiscal year.
- Shares opened at $62.21 (down ~3.7%), trade in a 52-week range of $31.36–$104.32, with a market cap of $11.07 billion, high volatility (beta 4.99) and a consensus "Hold" rating with an average target of $85.36 from analysts.
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) EVP Erik Phelps sold 1,302 shares of Tempus AI stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $67.42, for a total transaction of $87,780.84. Following the completion of the transaction, the executive vice president directly owned 89,280 shares in the company, valued at $6,019,257.60. This trade represents a 1.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Erik Phelps also recently made the following trade(s):
- On Tuesday, November 18th, Erik Phelps sold 3,533 shares of Tempus AI stock. The stock was sold at an average price of $65.54, for a total value of $231,552.82.
Tempus AI Trading Down 3.7%
Shares of TEM stock opened at $62.21 on Friday. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32. The stock's fifty day moving average price is $78.47 and its two-hundred day moving average price is $73.64. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28. The company has a market cap of $11.07 billion, a PE ratio of -52.28 and a beta of 4.99.
Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to analysts' expectations of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.Tempus AI's revenue was up 84.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.46) EPS. Equities analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. Needham & Company LLC raised their price target on shares of Tempus AI from $70.00 to $100.00 and gave the company a "buy" rating in a research note on Wednesday, November 5th. Guggenheim raised their target price on shares of Tempus AI from $80.00 to $95.00 and gave the company a "buy" rating in a research report on Friday, September 26th. BTIG Research boosted their target price on shares of Tempus AI from $96.00 to $105.00 and gave the stock a "buy" rating in a research note on Tuesday, November 25th. TD Cowen cut Tempus AI from a "buy" rating to a "hold" rating and set a $88.00 price target for the company. in a research note on Tuesday, October 21st. Finally, Canaccord Genuity Group cut their price objective on Tempus AI from $110.00 to $95.00 and set a "buy" rating on the stock in a report on Wednesday, November 5th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Tempus AI has a consensus rating of "Hold" and an average target price of $85.36.
Check Out Our Latest Analysis on TEM
Hedge Funds Weigh In On Tempus AI
Hedge funds have recently modified their holdings of the business. Cranbrook Wealth Management LLC acquired a new stake in Tempus AI in the third quarter valued at $25,000. Concord Wealth Partners lifted its holdings in Tempus AI by 308.0% during the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock worth $26,000 after buying an additional 308 shares during the period. JPL Wealth Management LLC bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $26,000. GAMMA Investing LLC acquired a new stake in shares of Tempus AI in the third quarter valued at about $28,000. Finally, Allworth Financial LP raised its position in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company's stock worth $29,000 after acquiring an additional 450 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company's stock.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
